Learn

What is a GLP-1, really?

A plain-English guide to the class of medications behind the last few years of weight-care headlines — and how the two most common molecules, semaglutide and tirzepatide, actually differ.

Semaglutide vialTirzepatide vial
RECOGNIZED BY LEADING MEDICAL ORGANIZATIONS
American Diabetes AssociationNew England Journal of MedicineMayo ClinicJAMACleveland ClinicThe Obesity SocietyEndocrine SocietyJohns Hopkins MedicineHarvard HealthAmerican Heart AssociationAmerican Diabetes AssociationNew England Journal of MedicineMayo ClinicJAMACleveland ClinicThe Obesity SocietyEndocrine SocietyJohns Hopkins MedicineHarvard HealthAmerican Heart Association

The short version

GLP-1 stands for glucagon-like peptide-1, a hormone your gut releases after you eat. It tells your pancreas to release insulin, tells your stomach to empty more slowly, and tells your brain that you're satisfied. GLP-1 medications are lab-made versions of that hormone that stay in your system for days instead of minutes — so the "I'm full" signal stays on long enough to reshape how much you actually eat.

In practice, most patients describe it as "food noise turning down." Cravings quiet. Portion sizes shrink on their own. Snacking loses its pull.

How they work in the body

  • Appetite regulation
    Acts on receptors in the brain that govern hunger and satiety.
  • Slower gastric emptying
    Food leaves the stomach more gradually, so you feel full longer after meals.
  • Insulin & blood sugar
    Triggers insulin release when glucose rises and reduces glucose production by the liver.
  • Metabolic effects
    Some GLP-1s also improve insulin sensitivity, which supports steadier energy day-to-day.

Semaglutide vs. Tirzepatide

Semaglutide
Tirzepatide
Class
Single-agonist (GLP-1)
Dual-agonist (GIP + GLP-1)
How it acts
Mimics GLP-1 to reduce appetite and slow gastric emptying.
Mimics both GLP-1 and GIP — pairs appetite control with improved insulin sensitivity.
Cadence
Once-weekly injection
Once-weekly injection
Typical dose range
0.25 mg → 2.5 mg / week
2.5 mg → 15 mg / week
Typical results
Steady, gradual weight loss over months.
Often stronger response at higher doses, especially past month 3.
Side-effect pattern
Mild GI symptoms early in titration (nausea, reflux) that usually settle.
Similar GI pattern; a slower titration typically improves tolerance.
Good starting fit if…
You want a gentler on-ramp or have responded well to GLP-1s before.
You want a stronger appetite response or GLP-1 alone has plateaued.

So which one is right for me?

Honestly, that's a conversation. A responsible answer depends on your starting point, other medications, how your body handles the first few weeks, and what "success" looks like for you. Our clinicians pick a starting molecule and dose with you — and adjust based on how you actually feel, not a preset schedule.

Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a licensed compounding pharmacy from a valid prescription written by a licensed provider.

Curious if a GLP-1 fits your goals? Let's find out together.

EVERYTHING WE OFFER

Our products, one shelf.